Page last updated: 2024-11-01

nicardipine and Cancer of the Thyroid

nicardipine has been researched along with Cancer of the Thyroid in 1 studies

Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inokuchi, N1
Zeki, K1
Morimoto, I1
Nakano, Y1
Fujihira, T1
Yamashita, U1
Yanagihara, N1
Izumi, F1
Eto, S1

Other Studies

1 other study available for nicardipine and Cancer of the Thyroid

ArticleYear
Stimulatory effect of interleukin-1 alpha on proliferation through a Ca2+/calmodulin-dependent pathway of a human thyroid carcinoma cell line, NIM 1.
    Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:7

    Topics: Biological Transport; Calcium; Calcium Channel Blockers; Calmodulin; Cell Division; Cell Line; Colfo

1995